chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Biopsy, Blood test, Computerised tomogram abdomen abnormal, Condition aggravated, Discomfort
Clinical narrative: FEVER; FATIGUE; EXTREME JOINT PAIN IN ARMS AND HANDS; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's concurrent conditions included neuroendocrine tumor. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 02-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested.  Concomitant medications included octreotide acetate for neuroendocrine tumor. On APR-2021, the subject experienced extreme joint pain in arms and hands. On APR-2021, the subject experienced fatigue. On 02-APR-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 101.8 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fever, fatigue and extreme joint pain in arms and hands was not reported. This report was non-serious.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Hepatic enzyme increased, Neuroendocrine tumour, Pain
Clinical narrative: FEVER; FATIGUE; EXTREME JOINT PAIN IN ARMS AND HANDS; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's concurrent conditions included neuroendocrine tumor. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 02-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested.  Concomitant medications included octreotide acetate for neuroendocrine tumor. On APR-2021, the subject experienced extreme joint pain in arms and hands. On APR-2021, the subject experienced fatigue. On 02-APR-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 101.8 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fever, fatigue and extreme joint pain in arms and hands was not reported. This report was non-serious.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Chills, Decreased appetite, Dyspepsia, Nausea
Clinical narrative: BODY ACHES; LOSS OF APPETITE; DYSPEPSIA; UPPER CHEST DISCOMFORT; SORE THROAT; CHILLS; NAUSEA; SHAKING; This spontaneous report received from a health care professional concerned a 32 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included iodine allergy, personality disorder, alcohol dependence, opioid dependence, seizure, and adjustment disorder.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1805025 expiry: UNKNOWN) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 12-APR-2021, the subject experienced shaking. On 12-APR-2021, the subject experienced chills. On 12-APR-2021, the subject experienced nausea. On 13-APR-2021, the subject experienced body aches. On 13-APR-2021, the subject experienced loss of appetite. On 13-APR-2021, the subject experienced dyspepsia. On 13-APR-2021, the subject experienced upper chest discomfort. On 13-APR-2021, the subject experienced sore throat. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from body aches, loss of appetite, dyspepsia, nausea, chills, shaking, upper chest discomfort, and sore throat. This report was non-serious. This case, from the same reporter.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pain, Tremor
Clinical narrative: BODY ACHES; LOSS OF APPETITE; DYSPEPSIA; UPPER CHEST DISCOMFORT; SORE THROAT; CHILLS; NAUSEA; SHAKING; This spontaneous report received from a health care professional concerned a 32 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included iodine allergy, personality disorder, alcohol dependence, opioid dependence, seizure, and adjustment disorder.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1805025 expiry: UNKNOWN) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 12-APR-2021, the subject experienced shaking. On 12-APR-2021, the subject experienced chills. On 12-APR-2021, the subject experienced nausea. On 13-APR-2021, the subject experienced body aches. On 13-APR-2021, the subject experienced loss of appetite. On 13-APR-2021, the subject experienced dyspepsia. On 13-APR-2021, the subject experienced upper chest discomfort. On 13-APR-2021, the subject experienced sore throat. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from body aches, loss of appetite, dyspepsia, nausea, chills, shaking, upper chest discomfort, and sore throat. This report was non-serious. This case, from the same reporter.
Sex: F
Vaccine: COVID19
Symptoms: Cough, Headache, Oropharyngeal pain, Pain, Rhinorrhoea
Clinical narrative: THROAT PAIN; PAIN; RUNNY NOSE; COUGH; HEADACHE; This spontaneous report received from a patient concerned a 31 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included patient has no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 09-APR-2021, the subject experienced throat pain. On 09-APR-2021, the subject experienced pain. On 09-APR-2021, the subject experienced runny nose. On 09-APR-2021, the subject experienced cough. On 09-APR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from cough, and had not recovered from headache, runny nose, pain, and throat pain. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Headache, Nausea, Pain, Pyrexia
Clinical narrative: BODY ACHES; FEVER; HEADACHE; NAUSEA; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 202A21A, expiry: UNKNOWN) dose was not reported, administered on 11-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 11-APR-2021, the subject experienced body aches. On 11-APR-2021, the subject experienced fever. On 11-APR-2021, the subject experienced headache. On 11-APR-2021, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, fever, headache, and nausea on APR-2021. This report was non-serious.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Oedema peripheral
Clinical narrative: FEET AND ANKLE SWELLING; DIZZY; This spontaneous report received from a patient concerned a 70 year old female. The patient's height, and weight were not reported. The patient's past medical history included chemotherapy treatment. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 207A21A, and expiry: 23-JUN-2021) dose was not reported, administered on 08-APR-2021 10:30 for prophylactic vaccination. Concomitant medications included potassium for swelling. On 08-APR-2021, the subject experienced dizzy. On 11-APR-2021, the subject experienced feet and ankle swelling. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from dizzy on 09-APR-2021, and had not recovered from feet and ankle swelling. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Injection site swelling, Pyrexia
Clinical narrative: FEVER; INJECTION SITE SWELLING; This spontaneous report received from a parent concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On APR-2021, Laboratory data included: Body temperature (NR: not provided) 102.4, 102.7. On an unspecified date, the subject experienced fever, and injection site swelling. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fever and injection site swelling was not reported. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: HEADACHE; This spontaneous report received from a patient concerned a 53 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and  expiry: UNKNOWN) dose was not reported, administered on 03-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from headache. This report was non-serious.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: HEADACHE; This spontaneous report received from a patient concerned a 42 year old female. The patient's weight was 155 pounds, and height was 62 inches. The patient's concurrent conditions included diabetes, non-smoker, and non-alcoholic, and other pre-existing medical conditions included patient does not abuse drug or illicit drug use. The patient experienced ibuprofen allergy when treated with ibuprofen.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A, and  expiry: 23-JUN-2021) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 13-APR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from headache. This report was non-serious.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Body temperature, Injection site pain, Nausea, Pyrexia
Clinical narrative: STABBING PAIN IN STOMACH; NAUSEA; INJECTION SITE SORENESS; FEVER; LOSS OF 5-6 POUNDS; This spontaneous report received from a patient concerned a 62 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included asthma, penicillin allergy, and keflex, tylenol and asprin allergy. The patient experienced difficulty in breathing when treated with hydrocodone bitartrate/paracetamol, and hives when treated with naproxen sodium, erythromycin, and swelling of the face when treated with magnesium sulfate.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and expiry: 21-JUN-2021) dose was not reported, administered on 01-APR-2021 for prophylactic vaccination.  No concomitant medications were reported.  On APR-2021, the subject experienced loss of 5-6 pounds. On 01-APR-2021, the subject experienced stabbing pain in stomach. On 01-APR-2021, the subject experienced nausea. On 01-APR-2021, the subject experienced injection site soreness. On 01-APR-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 101 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from injection site soreness, and fever on 03-APR-2021, had not recovered from nausea, and stabbing pain in stomach, and the outcome of loss of 5-6 pounds was not reported. This report was non-serious.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Weight decreased
Clinical narrative: STABBING PAIN IN STOMACH; NAUSEA; INJECTION SITE SORENESS; FEVER; LOSS OF 5-6 POUNDS; This spontaneous report received from a patient concerned a 62 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included asthma, penicillin allergy, and keflex, tylenol and asprin allergy. The patient experienced difficulty in breathing when treated with hydrocodone bitartrate/paracetamol, and hives when treated with naproxen sodium, erythromycin, and swelling of the face when treated with magnesium sulfate.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and expiry: 21-JUN-2021) dose was not reported, administered on 01-APR-2021 for prophylactic vaccination.  No concomitant medications were reported.  On APR-2021, the subject experienced loss of 5-6 pounds. On 01-APR-2021, the subject experienced stabbing pain in stomach. On 01-APR-2021, the subject experienced nausea. On 01-APR-2021, the subject experienced injection site soreness. On 01-APR-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 101 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from injection site soreness, and fever on 03-APR-2021, had not recovered from nausea, and stabbing pain in stomach, and the outcome of loss of 5-6 pounds was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Muscular weakness, Pain
Clinical narrative: HORRIBLE PAIN; WEAKNESS IN ARM; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced horrible pain, and weakness in arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the horrible pain and weakness in arm was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Exposure via breast milk
Clinical narrative: VACCINE EXPOSURE VIA BREAST MILK; This spontaneous report received from a consumer concerned a 9 month old female. The patient's weight, height, and medical history were not reported. The patient's parent received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 19-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced vaccine exposure via breast milk. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of vaccine exposure via breast milk was not reported. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Gait disturbance, Myalgia, Pain in extremity
Clinical narrative: BARELY WALK; PAIN IN RIGHT LEG MORE LIKE IN CALF; MUSCLE ACHE; PAIN IN RIGHT LEG MORE LIKE IN CALF; This spontaneous report received from a patient concerned a 64 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 13-APR-2021, the subject experienced pain in right leg more like in calf. On an unspecified date, the subject experienced barely walk, pain in right leg more like in calf, and muscle ache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from pain in right leg more like in calf, and the outcome of muscle ache, barely walk and pain in right leg more like in calf was not reported. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Hypersensitivity
Clinical narrative: ALLERGIC REACTION; This spontaneous report received from a consumer via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, unknown, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the subject experienced allergic reaction. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of allergic reaction was not reported. This report was non-serious.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Dizziness, Hyperhidrosis, Nausea
Clinical narrative: LIGHTHEADEDNESS; SWEATING; VOMITING; CHILLS; NAUSEA; FEVER; This spontaneous report received from a patient concerned a 20 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 202A21A, expiry: UNKNOWN) dose was not reported, administered on 10-APR-2021; 10:40 for prophylactic vaccination. No concomitant medications were reported. On 10-APR-2021, the subject experienced lightheadedness. On 10-APR-2021, the subject experienced sweating. On 10-APR-2021, the subject experienced vomiting. On 10-APR-2021, the subject experienced chills. On 10-APR-2021, the subject experienced nausea. On 10-APR-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 99 F. Treatment medications (dates unspecified) included: mepyramine maleate/pamabrom/paracetamol, and paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills, and fever on APR-2021, and had not recovered from nausea, lightheadedness, sweating, and vomiting. This report was non-serious.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vomiting
Clinical narrative: LIGHTHEADEDNESS; SWEATING; VOMITING; CHILLS; NAUSEA; FEVER; This spontaneous report received from a patient concerned a 20 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 202A21A, expiry: UNKNOWN) dose was not reported, administered on 10-APR-2021; 10:40 for prophylactic vaccination. No concomitant medications were reported. On 10-APR-2021, the subject experienced lightheadedness. On 10-APR-2021, the subject experienced sweating. On 10-APR-2021, the subject experienced vomiting. On 10-APR-2021, the subject experienced chills. On 10-APR-2021, the subject experienced nausea. On 10-APR-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 99 F. Treatment medications (dates unspecified) included: mepyramine maleate/pamabrom/paracetamol, and paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills, and fever on APR-2021, and had not recovered from nausea, lightheadedness, sweating, and vomiting. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity
Clinical narrative: MILD HEADACHES; BILATERAL LEG PAIN/ WORSE ON RIGHT LEG; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included penicillin allergy, abstains from alcohol, and non-smoker, and other pre-existing medical conditions included no drug abuse/ illicit drug use. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805022, expiry: UNKNOWN) dose was not reported, administered on 18-MAR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 08-APR-2021, the subject experienced bilateral leg pain worse on right leg. On an unspecified date, the subject experienced mild headaches. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from bilateral leg pain worse on right leg, and mild headaches. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: ITCHY ARM; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced itchy arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of itchy arm was not reported. This report was non-serious.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Skin discolouration
Clinical narrative: BLACK SPOT INSIDE THE LEFT SIDE OF THE CHEEK (INSIDE); This spontaneous report received from a patient concerned a 50 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A, and batch number: 043A21A expiry: /6/2021) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 14-APR-2021, the subject experienced black spot inside the cheek. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from black spot inside the cheek. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Injection site pain
Clinical narrative: DIZZY; ARM A LITTLE SORE; This spontaneous report received from a patient concerned a 56 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included sinus infection. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 207A21A, and expiry: 23-JUN-2021) dose was not reported, administered on 11-APR-2021 for prophylactic vaccination. Concomitant medications included amlodipine for blood pressure, hydrochlorothiazide for blood pressure, losartan for blood pressure, and prednisone for sinus infection. On 11-APR-2021, the subject experienced arm a little sore. On 14-APR-2021, the subject experienced dizzy. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from dizzy, and arm a little sore. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: HEADACHES; This spontaneous report received from a consumer concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The company was unable to perform follow up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the subject experienced headaches. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of headaches was not reported. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Therapeutic response unexpected
Clinical narrative: ENORMOUS AMOUNT OF ENERGY PATIENT NORMALLY DON'T HAVE; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case  No concomitant medications were reported.  On MAR-2021, the subject experienced enormous amount of energy patient normally don't have. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of enormous amount of energy i normally don't have was not reported. This report was non-serious.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: FATIGUE; This spontaneous report received from a patient concerned a 73 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805022, expiry: 25-MAY-2021) dose was not reported, administered on 31-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 31-MAR-2021, the subject experienced fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fatigue. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity, Pyrexia
Clinical narrative: BODY ACHES; LEG PAIN; FEVER; This spontaneous report received from a parent concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 09-APR-2021, the subject experienced body aches. On 09-APR-2021, the subject experienced leg pain. On 09-APR-2021, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, leg pain, and fever on 13-APR-2021. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Injection site pain, Muscle tightness, Pain
Clinical narrative: MUSCLE TIGHTNESS AT LEFT SIDE OF NECK; SWELLING AT LEFT SIDE OF NECK; MILD  BODY ACHES; FEVER 99 F; GENERAL TIREDNESS; LEFT ARM PAIN AT INJECTION SITE; This spontaneous report received from a patient concerned a 45 year old male. The patient's weight was 168 pounds, and height was 68 inches. The patient's pre-existing medical conditions included the patient had no known allergies there was no drug abuse or illicit drug usage, the patient was non alcoholic and non-smoker.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 202A21A, and  expiry: UNKNOWN) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 12-APR-2021, the subject experienced left arm pain at injection site. On 12-APR-2021, the subject experienced general tiredness. On 13-APR-2021, the subject experienced mild body aches. On 13-APR-2021, the subject experienced fever 99 F. Laboratory data included: Body temperature (NR: not provided) 99 F. On 14-APR-2021, the subject experienced muscle tightness at left side of neck. On 14-APR-2021, the subject experienced swelling at left side of neck. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from fever 99 F, mild body aches, and general tiredness, and had not recovered from swelling at left side of neck, left arm pain at injection site, and muscle tightness at left side of neck. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Swelling
Clinical narrative: MUSCLE TIGHTNESS AT LEFT SIDE OF NECK; SWELLING AT LEFT SIDE OF NECK; MILD  BODY ACHES; FEVER 99 F; GENERAL TIREDNESS; LEFT ARM PAIN AT INJECTION SITE; This spontaneous report received from a patient concerned a 45 year old male. The patient's weight was 168 pounds, and height was 68 inches. The patient's pre-existing medical conditions included the patient had no known allergies there was no drug abuse or illicit drug usage, the patient was non alcoholic and non-smoker.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 202A21A, and  expiry: UNKNOWN) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 12-APR-2021, the subject experienced left arm pain at injection site. On 12-APR-2021, the subject experienced general tiredness. On 13-APR-2021, the subject experienced mild body aches. On 13-APR-2021, the subject experienced fever 99 F. Laboratory data included: Body temperature (NR: not provided) 99 F. On 14-APR-2021, the subject experienced muscle tightness at left side of neck. On 14-APR-2021, the subject experienced swelling at left side of neck. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from fever 99 F, mild body aches, and general tiredness, and had not recovered from swelling at left side of neck, left arm pain at injection site, and muscle tightness at left side of neck. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Headache, Nausea, Vomiting
Clinical narrative: HEADACHE; VOMITING; NAUSEA; This spontaneous report received from a patient concerned a male of unspecified age. The patient's height, and weight were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 12-APR-2021 16:00 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On 12-APR-2021, the subject experienced vomiting. On 12-APR-2021, the subject experienced nausea. On 13-APR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from nausea, vomiting, and headache. This report was non-serious.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Dissociation, Dizziness, Injection site paraesthesia
Clinical narrative: NOT FEELING TOO AWARE; DIZZY; TINGLING AT INJECTION SITE; WEAKNESS ALL OVER BODY; This spontaneous report received from a patient concerned a 27 year old male. The patient's height, and weight were not reported. The patient's past medical history included traumatic brain injury. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 041A21A, expiry: 21-JUN-2021) dose was not reported, administered on 29-MAR-2021 13:00 for prophylactic vaccination. No concomitant medications were reported. On 29-MAR-2021, the subject experienced not feeling too aware. On 29-MAR-2021, the subject experienced dizzy. On 29-MAR-2021, the subject experienced tingling at injection site. On 29-MAR-2021, the subject experienced weakness all over body. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from tingling at injection site, and weakness all over body on 2021, and had not recovered from not feeling too aware, and dizzy. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: HEADACHES WITH THE WORST ONSET BEING THIS MORNING AS SHE HAD TO LAY DOWN; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's past medical history included blood clotting disorder. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on APR-2021 for prophylactic vaccination. The batch number was not reported. The company was unable to perform follow-up to request batch/lot number. No concomitant medications were reported. On APR-2021, the subject experienced headaches with the worst onset being this morning as she had to lay down. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of headaches with the worst onset being this morning as she had to lay down was not reported. This report was non-serious.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site rash, Rash erythematous, Rash papular, Rash pruritic
Clinical narrative: Raised/itchy rash at the site of the injection. Two days later, the rash flattened out in a wide/red/itchy rash.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia oral
Clinical narrative: Patient reported tingling and funny feeling in lips and tip of tongue.  Patient had no other symptoms of swelling, pain, or trouble swallowing or breathing.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pain, Pain in extremity
Clinical narrative: Arm was sore later in the day of vaccine.  About 15 hours after vaccine, developed chills for about 2 hours.  Woke up the next morning with headache, body aches and arm still sore.  Lasted about 8 hours.  Did not take any medications to alleviate any symptoms.
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster, Mouth ulceration, Rash, Toothache
Clinical narrative: shingles to right top of head, ulcers in mouth, teeth pain, and rash to right side of face. all symptoms are right sided
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Abortion spontaneous, Blood test, Chills, Exposure during pregnancy, Headache
Clinical narrative: I received my second vaccine dose on Friday, 4/16. At the time I was 6 weeks and 4 days pregnant. I woke up at three o'clock in the morning on Saturday, 4/17 sweating with chills, body aches and a headache. When I went to the bathroom at six o'clock AM I noticed that I was bleeding. I called my doctor and she told me to monitor the bleeding over the weekend and to call first thing Monday morning for an ultrasound. I continued bleeding throughout the weekend and yesterday (4/19) my doctor confirmed that I was experience a miscarriage.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperhidrosis, Pain, Ultrasound scan, Vaginal haemorrhage
Clinical narrative: I received my second vaccine dose on Friday, 4/16. At the time I was 6 weeks and 4 days pregnant. I woke up at three o'clock in the morning on Saturday, 4/17 sweating with chills, body aches and a headache. When I went to the bathroom at six o'clock AM I noticed that I was bleeding. I called my doctor and she told me to monitor the bleeding over the weekend and to call first thing Monday morning for an ultrasound. I continued bleeding throughout the weekend and yesterday (4/19) my doctor confirmed that I was experience a miscarriage.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Electrocardiogram abnormal, Hypokalaemia, Supraventricular tachycardia, Tachycardia
Clinical narrative: Pfizer-BioNTech COVID-19 Vaccine EUA: two days after vaccination patient presents to emergency department (ED) tachycardic (heart rate 180s) found to be in SVT and hypokalemic. Blood pressure normal and denies chest pain. Vagal manuvers did not resolve SVT. Administered adenosine with resolution of SVT. Administered oral potassium replacment and discharged to home stable.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Dry throat, Throat irritation
Clinical narrative: Patient complained of itchy and dry throat. Denies swelling, difficulty breathing, and itching. The doctor on site evaluated her. Vital signs stable. Felt better after drinking water. No problem swallowing. Symptoms resolved completely and she was discharged from the vaccine clinic.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Bell's palsy, Blood test, Computerised tomogram, Electrocardiogram, Nodule
Clinical narrative: Knot under left arm 04/06/2021   -04/08/2021 Bell's Palsy 04/09/2021 to present
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Headache, Myalgia, Nausea
Clinical narrative: Nausea after 2 minutes, lasted about 5 minutes.  Light headedness after 2 minutes very pronounced for about 15 minutes then eased up but lasted all day. Fatigue  after 2 minutes,  still ongoing today. Muscle aches, within an hour and still continuing though gradually improving. Odd taste and sensations in mouth after a minute lasting about 20 minutes.  Slight fever (99.8) in afternoon but gone next morning. Headache within a minute, still ongoing ar this time
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Taste disorder
Clinical narrative: Nausea after 2 minutes, lasted about 5 minutes.  Light headedness after 2 minutes very pronounced for about 15 minutes then eased up but lasted all day. Fatigue  after 2 minutes,  still ongoing today. Muscle aches, within an hour and still continuing though gradually improving. Odd taste and sensations in mouth after a minute lasting about 20 minutes.  Slight fever (99.8) in afternoon but gone next morning. Headache within a minute, still ongoing ar this time
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Our health department conducted a mass vaccination event on 4/3/21 where more than 1,000 people were vaccinated. Over the course of the 8 hr event there were 10 16&17 yo patients who received a first dose of Moderna vaccine. We have reported this to Moderna and they recommended we fill out a VAERS for each patient. We have spoken with the parents of each patient. There were no reported adverse effects and all of them are planning on getting their second shot of Moderna Vaccine.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Asthma, Dyspnoea
Clinical narrative: Asthma, Shortness of breath increased in severity by 4/15 or so. Has continued until present. I start to run out of breath when I reach the top of my stairs. I recover appx 3 min of rest. No increases in severity for the past 5 days. No fever, phlem, or mucus. Only breathlessness. Easier to sleep on an incline. (I must move too much in bed.)
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia oral, Lip swelling, Paraesthesia oral
Clinical narrative: Patient waited in pharmacy for 25 minutes. Upon return home patient felt tingling and numbness in the lips. Patient reported swelling in lips. Patient was advised to take Benadryl and seek medical attention at nearest ER or urgent care. Patient spoke to nurse on phone and advised to take Benadryl at home after complete consultation of symptoms over the phone.  Patient symptoms resolved with Benadryl and did not seek further medical attention.  Upon follow-up call in AM of 4/20/21 patient reported symptoms had resolved and was doing good.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea
Clinical narrative: Lungs lost a lot of capacity which I was able to gauge by my swimming as well as being easily out of breath which is not normal
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal discomfort, Diarrhoea, Headache, Injection site pain, Musculoskeletal stiffness
Clinical narrative: *had mild arm soreness and stiffness at injection site in upper arm muscle for both vaccine series #1 and #2. The arm soreness was present for several days after the vaccines, but diminishing. *had what I would describe as NOT an ongoing headache, but rather  a few sharp shooting pains in head within first several hours of having Vaccine # 2. These only lasted a second or two each time although they re-occurred 3 or 4 times, and were tolerable. *had upset stomach with mild diarrhea the same evening after having vaccine#2, and later severe diarrhea again the next morning  after having had vaccine#2 the prior day. The severe diarrhea bout iI described in the morning after vaccine # 2 was sudden and uncontrollable, which woke me up and caused me to soil myself before reaching the bathroom. There was no stool consistency whatsoever, very watery diarrhea.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Sleep disorder
Clinical narrative: *had mild arm soreness and stiffness at injection site in upper arm muscle for both vaccine series #1 and #2. The arm soreness was present for several days after the vaccines, but diminishing. *had what I would describe as NOT an ongoing headache, but rather  a few sharp shooting pains in head within first several hours of having Vaccine # 2. These only lasted a second or two each time although they re-occurred 3 or 4 times, and were tolerable. *had upset stomach with mild diarrhea the same evening after having vaccine#2, and later severe diarrhea again the next morning  after having had vaccine#2 the prior day. The severe diarrhea bout iI described in the morning after vaccine # 2 was sudden and uncontrollable, which woke me up and caused me to soil myself before reaching the bathroom. There was no stool consistency whatsoever, very watery diarrhea.
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Syncope
Clinical narrative: 3 days after receiving Pfizer COVID-19 vaccine patient experienced a syncopal episode while at school.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Patient was given vaccine that had been in refrigerated temperature for 7 days (outside length of time advised in EUA). No adverse events have been reported at this time. We are speaking with company regarding re-immunization.
Age: 1.25
Sex: M
Vaccine: DTAPIPVHIB, PNC13
Symptoms: Pyrexia, Seizure
Clinical narrative: Mom reports seizure activity at home around 6 pm. Mom did not notice anything that stood out from his normal behavior. Paramedic's were called post seizure activity and child was checked out to be stable with a fever of 102.
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chest pain, Dyspnoea, Headache
Clinical narrative: Headache SOB Chest Pain
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dyspnoea, Headache
Clinical narrative: Headache SOB Chest Pain
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Dizziness, Fatigue, Headache, Laboratory test normal
Clinical narrative: about 6 days later I started getting bad headaches, on and off. Leg pain, joint pain, dizzyness on and off and overall tiredness. 9 days later I started noticing odd bruises on my legs and arms. I am overall tired and achy. The headache comes and goes and I need to take tylenol.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Magnetic resonance imaging normal, Pain, Pain in extremity
Clinical narrative: about 6 days later I started getting bad headaches, on and off. Leg pain, joint pain, dizzyness on and off and overall tiredness. 9 days later I started noticing odd bruises on my legs and arms. I am overall tired and achy. The headache comes and goes and I need to take tylenol.
Age: 96.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Electrocardiogram, Fall, Lethargy, Miosis
Clinical narrative: Lethargic, pale, glassy and pinpoint eyes to unresponsive, limp and falling to the right side. Client laid on ground due to unresponsiveness and unable to obtain vitals, client gasped when laid flat then  reported nausea, rolled to side client started vomiting. EMS called, EKG ran, client refused services. Walked out of clinic.
Age: 96.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Pallor, Unresponsive to stimuli, Vomiting
Clinical narrative: Lethargic, pale, glassy and pinpoint eyes to unresponsive, limp and falling to the right side. Client laid on ground due to unresponsiveness and unable to obtain vitals, client gasped when laid flat then  reported nausea, rolled to side client started vomiting. EMS called, EKG ran, client refused services. Walked out of clinic.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal distension, Feeding disorder, Injection site swelling, Weight decreased
Clinical narrative: - recurring swelling at site lasting 4 weeks - bloating, swelling in stomach - cannot eat properly - weight loss
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headache, right sided. Mild-moderate severity. Persistent.
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Throat irritation
Clinical narrative: Patient states that apporximately 12 hours after the vaccine he felt like a piece of food was stuck in his throat.  He tried making himself vomit, without results.  The feeling of something in his throat continued and felt it was getting worse for 2-3 days.  He took Ibuprofen which seemed to help.  After 4-5 days the smptom resolved.  Patient did not seek any medical attention.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure decreased, Electrocardiogram, Loss of consciousness, Paraesthesia, Presyncope
Clinical narrative: Immediately after receiving vaccine, pt had complete loss of consciousness for approximately 30-45 seconds.  Pt was lowered to the floor and placed in trendelenburg.  BP 132/71, HR 93, 98% on RA.  BP 10 minutes later with pt lying down dropped to 83/49, HR 52 and 99% on RA.  Each time we attempted to have pt sit up, Pt would begin to have tingling in extremities and ringing in ears.  EMS called.  BP eventually raised to 127/66 with pt sitting upright but EMS preferred to transport pt to Hospital. Pt evaluated in ED and notes indicate that EKG was done and revealed normal sinus rhythm. Determined to be vasovagal reaction leading to syncope. Pt discharged to home in stable condition.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Syncope, Tinnitus
Clinical narrative: Immediately after receiving vaccine, pt had complete loss of consciousness for approximately 30-45 seconds.  Pt was lowered to the floor and placed in trendelenburg.  BP 132/71, HR 93, 98% on RA.  BP 10 minutes later with pt lying down dropped to 83/49, HR 52 and 99% on RA.  Each time we attempted to have pt sit up, Pt would begin to have tingling in extremities and ringing in ears.  EMS called.  BP eventually raised to 127/66 with pt sitting upright but EMS preferred to transport pt to Hospital. Pt evaluated in ED and notes indicate that EKG was done and revealed normal sinus rhythm. Determined to be vasovagal reaction leading to syncope. Pt discharged to home in stable condition.
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Joint swelling, Malaise, Paraesthesia, Peripheral swelling
Clinical narrative: Patient reported that three days after receiving the vaccine, she developed swelling in left leg, ankle, hip, shoulder and hand. The symptoms stayed for a week and patient's leg was tingling, left hip aching, left shoulder pain, left hand feels like pins and needles, Achy all over and felt unwell.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Injury associated with device, No adverse event
Clinical narrative: patient had no adverse event. I was stuck by needle upon capping needle.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Laryngitis, Pain, Throat irritation
Clinical narrative: muscle aches, larygnitits, scratchy throat.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Thrombosis
Clinical narrative: pt developed symptoms on 4/19/2021 after receiving shot on 4/7/2021.  Patient was admitted to hospital and discovered to have a clot in left leg.  Patient is receiving Lovenox.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Pain, Pyrexia
Clinical narrative: Tired, headache, fever, chills, body aches, started the morning after the shot, lasted for one day.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Headache, Migraine, Nasal congestion, Pain
Clinical narrative: Very High Fever followed by aches and pains with congestion then a severe headache like a migraine and ending with 3-4 days of diarrhea